52.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$54.31
Aprire:
$54.91
Volume 24 ore:
410.84K
Relative Volume:
1.12
Capitalizzazione di mercato:
$2.92B
Reddito:
$226.84M
Utile/perdita netta:
$3.55M
Rapporto P/E:
742.86
EPS:
0.07
Flusso di cassa netto:
$-12.02M
1 W Prestazione:
-8.92%
1M Prestazione:
-12.69%
6M Prestazione:
+8.13%
1 anno Prestazione:
+8.04%
Vericel Corp Stock (VCEL) Company Profile
Nome
Vericel Corp
Settore
Industria
Telefono
(734) 930-5555
Indirizzo
64 SIDNEY ST., CAMBRIDGE, MA
Confronta VCEL con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
VCEL
Vericel Corp
|
52.00 | 2.92B | 226.84M | 3.55M | -12.02M | 0.07 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-09 | Iniziato | Canaccord Genuity | Buy |
2024-06-20 | Iniziato | TD Cowen | Buy |
2024-01-25 | Aggiornamento | Truist | Hold → Buy |
2023-08-08 | Aggiornamento | BTIG Research | Neutral → Buy |
2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
2022-11-09 | Downgrade | Truist | Buy → Hold |
2022-10-14 | Ripresa | Stephens | Overweight |
2021-01-11 | Downgrade | Oppenheimer | Outperform → Perform |
2020-12-18 | Iniziato | Stephens | Overweight |
2020-09-17 | Iniziato | Truist | Buy |
2019-10-09 | Iniziato | H.C. Wainwright | Buy |
2019-02-28 | Downgrade | Needham | Buy → Hold |
2018-08-08 | Reiterato | Needham | Buy |
2018-07-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
2018-04-04 | Iniziato | Leerink Partners | Outperform |
2018-03-06 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
2018-03-06 | Reiterato | Needham | Buy |
2018-03-05 | Reiterato | BTIG Research | Buy |
2017-06-21 | Iniziato | BTIG Research | Buy |
2017-03-13 | Reiterato | Needham | Buy |
2016-12-22 | Iniziato | Piper Jaffray | Overweight |
2016-11-09 | Reiterato | Needham | Buy |
2016-04-05 | Downgrade | BofA/Merrill | Buy → Neutral |
2016-03-11 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Vericel Corp Borsa (VCEL) Ultime notizie
New York State Common Retirement Fund Has $46.94 Million Stake in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Kornitzer Capital Management Inc. KS Makes New Investment in Vericel Co. (NASDAQ:VCEL) - MarketBeat
TimesSquare Capital Management LLC Has $34.71 Million Stock Holdings in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel Co. (NASDAQ:VCEL) Shares Sold by Legato Capital Management LLC - MarketBeat
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Congress Asset Management Co. - MarketBeat
Vericel director Kevin McLaughlin sells shares worth $388,250 - MSN
Yousif Capital Management LLC Trims Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Jonathan Siegal Sells 1,092 Shares of Vericel Co. (NASDAQ:VCEL) Stock - MarketBeat
Vericel Co. (NASDAQ:VCEL) Director Sells $156,250.00 in Stock - MarketBeat
Vericel (NASDAQ:VCEL) Sets New 52-Week HighHere's Why - MarketBeat
Vericel's principal accounting officer sells $67,693 in stock - MSN
Vericel's principal accounting officer sells $67,693 in stock By Investing.com - Investing.com Australia
Vericel director Robert Zerbe sells $156,250 in stock - Investing.com India
Vericel Co. (NASDAQ:VCEL) Insider Jonathan Siegal Sells 1,092 Shares - Armenian Reporter
Vericel director Robert Zerbe sells $156,250 in stock By Investing.com - Investing.com Canada
Conestoga Capital Advisors LLC Sells 6,300 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Canaccord Genuity Group Increases Vericel (NASDAQ:VCEL) Price Target to $67.00 - MarketBeat
Vericel Corp [NASDAQ: VCEL] Sees Increase in Stock Value - Knox Daily
Vericel (NASDAQ:VCEL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Brokerages Set Vericel Co. (NASDAQ:VCEL) PT at $62.14 - Defense World
Vericel Co. (NASDAQ:VCEL) Receives $62.14 Average Price Target from Analysts - MarketBeat
SG Americas Securities LLC Trims Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
What 7 Analyst Ratings Have To Say About Vericel - Benzinga
Canaccord raises Vericel stock target to $67, maintains buy rating - Investing.com
Vericel Co. (NASDAQ:VCEL) Insider Sells $242,256.92 in Stock - MarketBeat
SG Americas Securities LLC Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Sets New 1-Year HighStill a Buy? - MarketBeat
VCEL Stock Touches 52-Week High at $61.5 Amidst Strong Growth - MSN
Park Avenue Securities LLC Takes $280,000 Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Park Avenue Securities LLC Buys Shares of 5,099 Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
Vericel (NASDAQ:VCEL) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail
Equities Analysts Set Expectations for Vericel Q3 Earnings - MarketBeat
Vericel (NASDAQ:VCEL) Earns “Overweight” Rating from Stephens - Defense World
FY2024 EPS Estimates for Vericel Reduced by HC Wainwright - Defense World
FY2024 Earnings Estimate for Vericel Issued By HC Wainwright - MarketBeat
Vericel expects 2024 net revenue in range of $237 to $237.5 million - MSN
Analyst supports Vericel stock outlook citing MACI Arthro synergies and expansion plans - Investing.com
Vericel (NASDAQ:VCEL) Shares Gap DownShould You Sell? - MarketBeat
Vericel (NASDAQ:VCEL) Receives "Overweight" Rating from Stephens - MarketBeat
Vericel Corp Azioni (VCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):